# A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

> **NCT06644118** · PHASE1 · RECRUITING · sponsor: **Zhejiang University** · enrollment: 58 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** OL-101 infusion

## Key facts

- **NCT ID:** NCT06644118
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-23
- **Primary completion:** 2027-10
- **Final completion:** 2028-10
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2024-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06644118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06644118, "A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06644118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*